BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2697438)

  • 21. Autologous bone marrow rescue for patients with acute myelogenous leukemia: purging with hyperthermia and ether lipid in vitro.
    Min W; Kim D; Lee J; Park J; Kim C; Kim D
    Prog Clin Biol Res; 1994; 389():197-203. PubMed ID: 7700903
    [No Abstract]   [Full Text] [Related]  

  • 22. The use of cultured bone marrow cells for autologous transplantation in patients with acute myeloblastic leukemia.
    Testa NG; Coutinho L; Chang J; Morgenstern G; Scarffe JH; Dexter TM
    Haematol Blood Transfus; 1987; 31():75-8. PubMed ID: 3327789
    [No Abstract]   [Full Text] [Related]  

  • 23. Prognostic variables in bone marrow transplantation for secondary leukaemia and myelodysplastic syndromes: a survey of the working party on leukaemia.
    de Witte T; Hermans J; van Biezen A; Vernant J; Kolb H; Zwaan F; Vossen J; Lönnqvist B; Beelen D; Ferrant A
    Bone Marrow Transplant; 1991; 7 Suppl 2():40. PubMed ID: 1878713
    [No Abstract]   [Full Text] [Related]  

  • 24. Chemotherapy versus transplantation: I. Acute myelogenous leukemia.
    Gale RP; Butturini A
    Haematologica; 1989; 74(1):1-4. PubMed ID: 2498172
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of acute myelogenous leukaemia.
    Löwenberg B
    J Intern Med Suppl; 1997; 740():17-22. PubMed ID: 9350177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allogeneic BMT for AML in Zagreb.
    Labar B; Bogdanić V; Nemet D; Mrsić M; Pavletić Z; Zupancić S; Radman I; Aurer I
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():86-7. PubMed ID: 2697413
    [No Abstract]   [Full Text] [Related]  

  • 27. Allogeneic marrow transplantation for acute non-lymphoblastic leukemia: first remission versus after first relapse.
    Buckner CD; Sanders J; Appelbaum FR
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():244-6. PubMed ID: 2653513
    [No Abstract]   [Full Text] [Related]  

  • 28. IBMTR analysis of bone marrow transplants in acute leukaemia. Advisory Committee of the International Bone Marrow Transplant Registry (IBMTR).
    Gale RP; Horowitz MM; Bortin MM
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():83-4. PubMed ID: 2697411
    [No Abstract]   [Full Text] [Related]  

  • 29. Bone marrow transplantation for myelodysplastic syndrome and secondary leukemia: outcome of 86 patients.
    Sutton L; Leblond V; Le Maignan C; Jouet JP; Kuentz M; Gluckman E; Blaise D; Marit G; Attal M; Troussard X
    Bone Marrow Transplant; 1991; 7 Suppl 2():39. PubMed ID: 1878712
    [No Abstract]   [Full Text] [Related]  

  • 30. [High-dose busulfan with subsequent bone marrow transplantation in poor-risk forms of leukemia].
    Urban C; Slavc I; Kaulfersch W; Teubl I
    Wien Klin Wochenschr; 1987 Mar; 99(5):144-9. PubMed ID: 3554777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autologous bone marrow transplantation improves disease free survival but not overall survival in people with acute myeloid leukaemia.
    Chauncey TR
    Cancer Treat Rev; 2004 Aug; 30(5):483-7. PubMed ID: 15245781
    [No Abstract]   [Full Text] [Related]  

  • 32. Donor leucocyte infusions after chemotherapy for patients relapsing with acute leukaemia following allogeneic BMT.
    Szer J; Grigg AP; Phillips GL; Sheridan WP
    Bone Marrow Transplant; 1993 Feb; 11(2):109-11. PubMed ID: 8435660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aclarubicin in the treatment of de-novo acute myelocytic leukaemia.
    Labar B; Nemet D; Minigo H; Bogdanić V; Jaksić B; Malesević M; Mrsić M
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():45-6. PubMed ID: 2697400
    [No Abstract]   [Full Text] [Related]  

  • 34. [Dose escalation study of high dose etoposide in autologous hematopoietic stem cell transplantation].
    Taniguchi S; Yamasaki K; Ohno Y; Hagimoto N; Higuchi K; Katoh M; Asayama R; Takita A; Hyodo S; Harada M
    Rinsho Ketsueki; 1993 Jul; 34(7):809-14. PubMed ID: 8103121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of acute myeloid leukaemia in first remission--chemotherapy versus bone marrow transplantation.
    De Witte T; De Pauw B; Holdrinet R; Janssen J; Haanen C
    Neth J Med; 1985; 28(7):281-4. PubMed ID: 3897880
    [No Abstract]   [Full Text] [Related]  

  • 36. [Outcome of autologous bone marrow transplantation in 73 patients with acute leukemia].
    Han M; Feng S; Li C
    Zhonghua Xue Ye Xue Za Zhi; 1998 Aug; 19(8):422-4. PubMed ID: 11189510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of peripheral blood stem cells for autologous transplantation in acute myeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cells.
    Visani G; Lemoli R; Tosi P; Martinelli G; Testoni N; Ricci P; Motta M; Gherlinzoni F; Leopardi G; Pastano R; Rizzi S; Piccaluga P; Isidori A; Tura S
    Bone Marrow Transplant; 1999 Sep; 24(5):467-72. PubMed ID: 10482929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Bone marrow transplantation in the treatment of acute leukemias].
    Moiseev SI; Ganapiev AA; Abdulkadyrov KM
    Ter Arkh; 1996; 68(12):8-10. PubMed ID: 9054052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Marrow grown in long-term culture can be used for autologous transplantation in the treatment of acute myeloid leukaemia.
    Chang J; Morgenstern GR; Testa NG; Dexter TM
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):597-600. PubMed ID: 2480315
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic factors for autologous bone marrow transplantation in acute leukaemia: a single centre study of 105 patients.
    Cordonnier JM; Mercier M; Plouvier E; Hervé P; Cahn JY
    Nouv Rev Fr Hematol (1978); 1994 Aug; 36(4):293-300. PubMed ID: 7971248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.